Most of the drugs discussed in this section are applied on
the skin. The skin has various functions:
Functions of skin
- protects internal body structure from hostile external environmental hazards (pollution, temperature, humidity and radiation)
- limits passage of chemicals into and out of the body
- acts as a microbilogical barrier
- stabilizes blood pressure and temperature
- mediates sensation of heat, cold, touch and pain
- Expresses emotions, e.g. embarrassment, anger, and anxiety (by sweating)
- Identifies the individual (color, hair, odor, and texture)
The dispersed systems in this section include Ointments,
creams, pastes and suppositories. Others are transdermal drug delivery
systems, lotions, topical solutions, linients, powders, gels, tinctures and
aerosols.
Ointments are
semisolid Preparations for external use which can be applied on skin or mucosae
with or without inunction. Ointments act as protective and emollients on skin,
but also may serve as vehicles for topical application of medicinal substances
and cosmetics. There exist also ophthalmic ointments which are sterile to be
applied in the eye.
Characteristics of ointments: Ointments should soften on
application but should not melt.
Usually, ointments are oleaginous (containing fatty
substances) but the definition of ointments includes substances of same
consistence although they may differ in appearance and containing no fatty
substances. White Ointment is Oleaginous while Polyethylene glycol (PEG)
ointment if free from oleaginous substances.
Creams are semisolid emulsions, usually medicated for
external applications. They can be oil-in-water (O/W) or water-in-oil (W/O).
There are also rectal and vaginal creams to be applied in the rectum and vagina
respectively.
Pastes are creams
and ointments containing a large amount of powder (solid material) and
therefore are much thicker or stiffer.
- Acting as protectants, lubricants or emmolients
- Drying effect
- Specific medicinal agents (antibiotics, antifungals, antivirals, antiseptics)
Preparations sold Over-the-Counter (OTC) contain mixtures of
medicinal substances used in the treatment of such conditions as minor skin
infections, itching, burns, diaper rashes and other rashes, insect stings, and
bites, skin diseases (e.g. eczema, psoriasis, athlete’s foot and acne)
Prescription skin preparation usually contain a single
medicinal agents intended to counter a specific diagnosis condition, but now
combination therapies are increasingly becoming common ( eg Quadriderm, Gentriderm,
and Gentrisone).
Historical
Background.
In ancient history, fats of animals were the basic vehicles
for formulating ointments. Evidence fro excavations in the tombs of Egyptians
Kings have given evidence of existence of ointments dating from 3000 -5000 BC.
Later on honey, wax, gums and resins and balsams and mucilages from plants were
used as bases for ointments.
The modern concept of ointments is a product of long development.
Earlier, liquids and semisolid such as cerates, poultices and pastes preparations
were all termed as ointments, but during the 13th century, separate
definitions were developed.
In the 19th C, the concept of ointment began to
broaden as natural bases were purified and used, and artificial bases were
developed. In 1858, Translucent jelly was prepared by heating glycerin and
starch. This is known as Unguentum glycerin BP.
1873 – Cosmolin and paraffin oil (Petrolatum)
1876 – Stearic acid (a substitute for white wax in over the
counter products(
1885 – Wool fat (lanolin) was rediscovered
1920 - Hydrogenated
oils, sulfated sulfonated hydrogenated
oils, polyethelene glycols
(PEG) and their esters wwere
discovered
1945 – Surface active agents (SAA) plastibase, attapulgite,
silicones, and veegum
1960 – Emulsion type especiallyecially oil-in-water. These
proved to be easily washed or
removed, promote percutaneous
absorption. Thus various creams are now found in pharmacopoeia eg Cold Cream,
Iodochlorohydroxyquin creams.
In summary, during the Greco-Roman time, ointment meant
anything to smear whether aqueous or oily. In modern times, ointment has a
broader meaning, including both fatty and aqueous hydrocarbon bases, e.g.
vanishing cream.
Medications used for
treatment on the skin include drugs for treatment of allergy, burns, local
itchiness and superficial skin disease. But other medications are used to treat
inner areas of the skin or even to provide systemic effects by penetrating
through the skin.
Medications used in treatment via skin
- Surface treatment (camouflage, sunscreen, skin barriers to prevent chapping, cosmetic application, topical antibiotics, antiseptics, and deodorants). The surface bioavailability requires the formulation to release (not bind to) medicament.
- Stratum corneum treatment: to improve emolliency or stimulate sloughing (keratolysis)
- Skin appendage treatment: to reduce hyperhydrosis of the sweat glands with antiperspirants (Aluminium chloride), treatment of acne with salicylic acid, tretinoin, or isotretinoin, topical antibiotics (eg framycetin and neomycin sulphate) and anti-fungals (clotrimazole, miconazole and ketoconazole)
- Epidermis and dermis treatment: steroidal and non steroidal anti-inflammatory agents and corticosteroids used in treatment of psoriasis, anaesthetics (benzocaine, amethocaine), antipruritis and antihistamins. May need penetration enhacers such as stratagems
- Transcutaneous immunization using topical vaccine antigens e.g.
- Systemic treatment via transdermal patches. This is a difficult approach because drugs are absorbed slowly, may be lost by washing or wiped by clothing, or by the sheded corneum scales. Also penetration depends on age, subject, conditions and sex. But there are examples in which this approach is followed e.g. nitroglycerin patches, nicorrete patches, transdermal scopolamine, nitroglycerin, oestradiol, clonidine and fentanyl.
PERCUTANEOUS ABSORPTION
Percutaneous absorption is a phenomenon associated with penetration
of medicament into and through skin to blood stream. There are several ways in
which drug penetrate the skin:
§ Between cells of stratum corneum,
§ Through cells of stratum corneum,
§ Through sweat glands,
§ Through sebaceous gland or
§ Through walls of hair follicles
Broken or abraded skin allow penetration easily but such
penetration is not true percutaneous
absorption.
After passage through the stratum corneum, (and through the
fatty layer and deeper epidermal layer finally into the dermis, drug may reach
vascularised dermal layer and become available for absorption into general
circulation. Subcutaneous layer behaves like a semi permeable membrane, and
drug molecules penetrate by passive diffusion.
When medications are applied on the skin the following
processes take place:
1. Drug
must be released from the vehicle/base
2. Drug
must penetrate into the skin layers
3. Pharmacological
action will be elicited.
SKIN SECTION MODE OF PENETRATION EXAMPLES OF
TREATMENT
Skin surface Drug
may dissolve, diffuse or Camouflage,
protective layer.
just be
released from the vehicle Insect repellants, antimicrobial
and antifungal.
Stratum corneum Partition of drug or diffusion Emolliency, Keratosis
To the stratum
corneum (Exfolients)
Appendages Antiperspirant,
exfolient
(through pilosebaceous antibiotic
antifungal
unit or ecrine gland) depilatory
Viable epidermis Partition or diffusion anti-inflammatory
through
viable epidermis anaesthetic,
Antihistamine
Dermis Partition
or diffusion Antipruritic
through
viable epidermis PUVA and
PDT
Circulation Removal via circulation Patch system
Nitroglycerin
Factors affecting
percutaneous absorption or Properties influencing Transdermal drug delivery:
Percutaneous absorption is
affected by
Ø The
condition of skin,
Ø Nature
of the drug,
Ø Nature
of the vehicle in which the drug is contained and
Ø hydration
of the skin
Ø area
where drug is applied
Ø length
of time the drug remains on skin, friction with which the drug is applied on skin
Anatomy and
physiology of skin
Skin Structure is complex. It
has three layers:
1. Epidermis
(avascular, cellural).
2. Dermis
(conectve tissue)
3. Hypodermis
Subcutaneous (fat)
In addition there are skin appendages (eccrine sweat glands,
apocrine sweat glands, hair and hair follicles and sebaceous glands)
(a)
Epidermis – this is the external, outer surface, about
0.1mm – 1mm
- Covered with discontinuous film of lipids
- Acidic (pH 4.5 – 6.5)
There are 5 layers – stratum
corneum (horny layer), S. lucidium
(barrier zone) s. granulosum (granular layer) S. malpighii (prickle cell layer)
s. germinatioum (basal cell layer).
S.
corneum: 10 – 50µ, general layers of
flattened keratinized cells which ore
constantly shed and replaced.
- offer Mechanical protection, retards water
loss, control entry of drugs.
S. lucidium: Acts as main barrier to skin penetration (even
water). Thought as extension of S. corneum. Following penetration of this zone,
penetrant is exposed to living tissues below.
S.
gerninatium: Growth of cells begin here,
multiply push against cells above them, progress, change shape and composition and
becomes horny.
(b) Dermis: this is known as true skin. It
is joined to epidermis but differ in
Composition/morphology. It has Collagen
+ Elastin fibres in gelatinous mucopolysacacharide medium
Also Blood and Lymph vessels are
contained here. There are also Hair follicles, and sebaceous gland.
(c) Hair
follicles, sweat glands, sebaceous glands
Potential pathway for drug
penetration through skin, but not important – why? There three times more sweat glands on
palms/soles yet tehse are less permeable (except for water) than the rest of
skin.
(d) Sebaceous glands. Play no significant role. They are richly
supplied
with blood vessels. They are known
to synthesize lipids.
- Skin, skin condition and other
biological factors.
Skin components complicate the
whole action of drug release and final absorption. Absorption of drugs will be
influenced / affected by
i.
Skin condition
i.
Presence of fats
under the skin,
ii.
enzymes,
iii.
presence of lymphatic
vessels,
iv.
interstitial
fluids,
v.
hair
follicles and
vi.
sweat glands.
ii.
Activity in skin
e.g. cell division, cell transport ,
cell surface loss will affect drug absorption in one way or another.
iii.
Disease of the
skin (eczema, psoriasis),
iv.
skin damage (scars, scratches, cuts,
blisters),
v.
presence of Cellular debris, sweat, sebum and surface
contaminants bring other unwanted effects.
vi.
Skin thickness: Regional skin sites differ. Eg thickness
of stratum corneum of the face, armpit, behind ear (or postauricular area) have
better absorptive rates, but palm, soles are not good sites. Postauricular area
has advantages: the layer is thinner, there are more sweat glands and sebaceous
glands per unit area, and capillaries are closer to the surface and has
relatively high temperature. )
vii.
Biological factors
i.
Blood flow
ii.
Skin metabolism (some medicines are metabolized under
the skin and reduce the concentration gradient e.g. steroids, and some chemical
carcinogens.
iii.
healing process
viii.
Inter-individual differences (some individuals sweat
profusely, some skins are softer, some are more hairy)
ix.
presence of chemicals, solvents
- Nature of the drug. (partition coefficient of the drug between vehicle and skin part, and aqueous /liquid solubility of the drug.
Absorption of the drug is said to
be by passive diffusion and therefore all factors that affect passive diffusion
will affect percutaneous absorption.
The
diffusion process.
The rate of transfer of materials per unit area, J, is
proportional to the concentration gradient. This is expressed by Fick’law:
J = -DδC/δχ
where C is the concentration of
diffusing substance, x is the space coordinate measured normal to the section
and D is the diffusion coefficient. The negative sign indicate that the flux is
in the direction of decreasing concentration.
Thus diffusion does not only depend on concentration
gradient and the area on which the drug is applied or even the skin thickness but also partition
coefficient between drug and skin, skin characteristics and diffusion
coefficient . Additionally there is a series of strata in the skin and hence
diffusion is not simple. Thus the diffusion resistance in all skin layers must
be considered:
RT = 1 = h1 + h2 + h3
PT D1K 1 D2K 2 D3K
3
Where RT is the total
resistance to permeation, PT is the thickness-weighted
permeability coefficient, K is the partition coefficient of drug and in vehicle
and skin and the numerals refer to the separate skin layers.
Unless on layer is extremely permeable compared to
other layers, the diffusion process is not simple but rather complex.
Furthermore the skin is selective, being easily penetrated by certain
substances and resistant to penetration by others. All physiological and physicochemical
characteristics must be considered by formulators.
Passive
diffusion:
Movement across skin is by passive diffusion. This is
evidenced by the fact that
1. Skin remains
impermeable long after removal from animal.
2. Fick’s law is
obeyed. The rate of diffusion is proportional to difference in concentration of
penetrant in and out of the skin.
3. Evidenced
that diffusional resistance is in stratum corneum, Sodium, water are actively
absorbed in stratum corneum.
Fick’s Law:
dQ/dt = DA (C1-C2)
x
dQ = quantity of drug transferred across
the membrane
dt = change in time, A = area where
diffusion is taking place.
C1 and C2 =
concentration of drug on either side, x = thickness of skin
D = diffusion coefficient.
Since DA/x is a constant,
dQ/dt = P (C1-C2)
where P = permeability constant.
When C1 = C2 the dynamic
equilibrium is reached.
Here the main characteristics of the penetrant which
determines its rate of penetration is
partition coefficient, Pk, and effective diffusivity in the skin, D. Of
these, Pk is more sensitive to molecular structure and size.
Formulation variables are not important except the
thermodynamic activity of the drug in the vehicle, which increase up to
saturation for a given vehicle.
2.1 Thus
Drug concentration in the vehicle is
important. Percutaneous absorption increase with increased concentration of the
drug in the vehicle.
2.1.1 Systems where the rate controlling
step to absorption is in the skin (the vehicle not appreciably affecting the
skin).
dq = P.C. C
DA PC = Effective distribution
dt x Coeff. of drug between vehicle and skin.
C =
(in the vehicle)
D = Average diffusivity in barrier
A = X-sectional area
x = Thickness of barrier
Here the main characteristics of penetrate which determine its rate of
penetration = PC and . Of these factors, PC is more important (varies greatly
than D) and is very sensitive to
molecular structure and size.
Formulation variable are not important
except the thermodynamic activity of drug in the vehicle which increase up to saturation for a given
vehicle.
2.1.2
Systems where the rate-controlling step is in the
applied base (drug is fine, insoluble and in suspension, C<A), large
concentration gradient develop in applied phase. Amount of drug released is
proportional to square root of concentration of drug per unit volume.
√ drug
concentration or
Volume
Drug solubility, diffusion constant and
time are not proportional to derug concentration. The instantaneous rate of
absorption at time t,
dq/dt
= √ADC
2t
Here, skin properties not important
(directly) but mostly – drug concentration
(A), Diffussion coeficient.D, and solubility Cs. : Rate is controlled by regulating A,D,Cs
A – no
problem
D - (
inversely proportional to Stoke –Einstein Equation and
varies with
viscosity)
Cs - Changes
according to pH and presence of
co-solvents
or Complexing
agents
2.1.2
Percutaneous absorption increase when a drug is applied
over a large area of the skin.
2.1.3
Percutaneous aborption is higher if the time of contact of the application is
increased. The longer the time the higher the application.
2.1.4
Concentration of
the drug in vehicle and hence concentration
gradient increase percutaneous absorption
2.1.5
The higher the Diffusion
coefficient of a drug in skin the higher the percutaneous absorption.
2.1.6
Ionization of the drug: only unionized species of a drug are absorbed. Ionization is affected by
temperature and pH.
2.1.7
Partition
coefficient (the stratum corneum –to-vehicle partition coefficient).
Although triamcinolone is more active than hydrocortisone when administered
systemically, but is only 1/5th active topically. In this context,
also presence of micelles or surface active agents has their effects.
2.1.8
Molecular size
and shape. The smaller the size of the drug molecule the more the
penetration.
2.1.2
- SKIN HYDRATION.
Protein, and protein degradation
products of the outer skin sorbs water very well, the amount of bound water
being a direct function of the relative humidity at a given temperature. (Not absolute amount of moisture in the
atmosphere).
Hydration may physically alter the skin tissue, also change
diffusion coefficient and Activity Coefficient of the penetrating drug, hence
increase rate of passage through the
skin.
Therefore, ointments with
available water for hydration e.g. o/w bases, can increase percutaneous absorption of some
drugs. In the same sense, bases which
tend to dehydrate the S. corneum (or do not maintain hydration of the skin decrease percutaneous absorption, For
example PEG is not a suitable base for water-soluble medicaments.
Bases e.g. Petrolatum, w/o
emulsions which leave occlusive films, induce hydration through sweat
accumulation. Degree of occlusion is
even greater with plastic film e.g Saran Wrap, especiallyecially with steroids
(Dexamethasone, triamcinolone acetonide.
Here Minimal Effective Concentration (MEC) is reduced by a factor of
100.
Protein and protein degradation of
the outer s (occlusion of skin increases hydration. Compare skin patches and
ointments and creams or protective films).
3.1 Drugs with more affinity to the skin than to the
vehicle leave the vehicle
easily and are
absorbed better.
3.2 drug absorption appears to be
enhanced from vehicles that easily cover
the skin surface, mix readily with sebum and bring the drug into
contact with tissue cells for absorption.
3.3 Vehicles that increase skin hydration generally increase
percutaneous
absorption of the drugs.
Oleagenous vehicles and /or occlusive bandages act as moisture barriers
therefore hydrate the skin
- Other factors
- Site of application – where keratic layer is thin, drugs pass readily – e.g. scrotal skin Vs palms, soles.
- Length of time the application remains on skin – absorption of time, the rate time as tissue saturates
- Amount of inunction used in application. The larger the period, the greater the absorption.
- Skin temperature: This varies with conditions in sparsely haired animals e.g. man. In cold weather rate is decreased, while in hot conditions rate is increased twice per 10o increase.
Ointment Bases
Characteristics of an ideal base:
- Non irritating, non sensitizing
- Non dehydrating
- Non greasy
- Compatible with common ingredients
- Stable
- Water washable (removable)
- Absorptive
- Absorb water
- Smooth and pliable
- Inert
- Readily release incorporated medicament
- Acceptable odour (free from objectionable odours)
- Easy to compound
There is no ointment base with all these qualities. But a
pharmacist should be able to recommend depending on the physical – chemical
properties, site of application as well as actors affecting absorption from
dermatological vehicles.
CLASSIFICATION OF BASES
A: Bases can be classified according to TYPE (based on
composition)
I. Oleaginous ointment base
i. Anhydrous
ii
does not absorb water readily (hydrophobic)
iii
insoluble in water
iv
not water removable
Examples of oleaginous bases
i.
Fats and
Fixed Oils:
a.
Lard (purified
internal fat of abdomen of hog was used extensively in the past but now
obsolete.
b. Fixed oils:Olive, Cotton seed, Sesame. Persil,
Sunflower oils.
Advantages: Emollient properties (induce hydration)
Disadvantages: Low WATER, WATER absorbing
capacities
Rancidity
(glycosides of fatty acids)
ii.
Hydrocarbon
Bases
a. Petrolatum, liquid petrolatum, with wax.
- Wide range of melting points
- Compatible with many ingredients
- Stable, odourless, tasteless, chemically
inert
- Same as occlusive coverings, induce
hydration, vehicle for ophthalmic ointments, antibiotics – are unstable in WATER
e.g Bacitracin.
- Do not rancidity
DISADVANTAGE: Greasy.
b. Plastibase – combination of
mineral oils + heavy
hydrocarbon waxes
- Soft,
unctuous, colourless, jelly-like
Melts at 90
– 91º, good consistency between -15º – 60º
- Does not liquefy tropics does not
harden in low temperatures
- Makes more elegant Ung than paraffin
- Release more drug than petrolatum
when exposed to o/w interface.
- No smooth consistency with wax.
c. Silicones:
Synthetic polymer – basic
structure O-Si-O-Si-O and may be liquid, resin or rubber depending on the type
of organic group attached.
- Demethylpolysiloxane
(DC 200 fluid) + L-45
- All
insoluble in WATER (and are water repellant)
- Inert
physiologically, non-toxic, non irritant.
- Used
widely in protective creams and lotions.
II Absorption ointment base
i.
Anhydrous
ii. Absorbs
water (hydrophilic)
iii. Insoluble
in water
iv. Most
are not water removable
Absorption here
means water absorbing properties – NOT action on skin.
-
Are anhydrous, capable of absorbing large quantity of water
while retaining their consistence.
-
Could be W/O emulsion e.g. hydrous lanolin
Anhydrous lanolin ,wool alcohol, aquabase
Hydrophilic petrolatum (o/w).
White wax, stearyl alcohol (have high Heat stability and high water
absorption capability)
Wool alcohols
·
The
ADVANTAGES of the bases is that
one can increase water in aqueous solutions of drugs, have high Index of
compatibility, are heat stable and can be elmulisified with WATER to increase emolliency
DISADVANTAGES They are still
greasy although they can be readily removed from skin than Oleagenous bases.
III Emulsion ointment base
w/o hydrous, absorbs water, insoluble in water,
not water removable
o/w hydrous, absorbs water, water soluble, water removable
Semi-solid
emulsions can be o/w or w/o,
- Can absorb water
- Wide range of products due to big new
organic compounds for use as wetting agents, emollient detergents, and
emulsifiers – Surface Active Agents (SAA) can be ionic or non-ionic.
Non ionic SAA are widely used in demotologicals – They do
not ionize (not affected by presence of ions e.g. hard water), less toxic,
non-instant, more stable.
Lanolin (compatible with skin
lipids
Cold cream USP
uses spermacet from whales).
Hydrophillic oint USP
Emulsilying oint BP
- They have tendency to lose water. Add Glyecrin, PEG, or propylene Glycol as
humectant. These are Hygroscopic, reduce
WATER loss through evaporation.
Anhydrous Emulsion bases (emulsifiable solids) have been developed as
a means of producing emulsions for extemporaneous compounding. These are
powders (easy weighing)
Emulsifying wax BP is Used to make
Emulsifying ointment which in turn is used in making Aqueous cream
IV water soluble bases Anhydrous adsorbs water, water
soluble, and water
removable,
greaseless.
-
Include bases prepared from higher ethylene glycol
polymers – PEC compounds (Carbowax).
PEG: HO-CH2 (CWATERCH2)x CWATERH
The macrogols are mixtures of
polycondensation compounds of ethylone oxide and water, and are described by
representing their average molecular weights.
Consistency varies from viscous liquids to waxy solids.
Macrogol 200 – 700 liquid
Mavrogol > 1000 semi solid
Macrogol >1500 waxy solids
-
Completely water soluble – easy removal from skin.
-
Non toxic, non- irritating, heat sterilizable,
hygroscopic
-
Consistency modified by mixing liquids with solids e.g.
Macrogol Oint BPC
Macrogol
300 65
parts
Macrogol 4000 35 parts
- Absorbed by skin: hence are good for drugs which need be
absorbed.
- Solvent power – can dissolve Hydrocortisone, Citric
Acid, sulphonamides and sulfurs.
- Free f rom greasiness, Eeasily spread
- Do not hydrolyse, rancidify, or support
microbial growth
- Compartible with many ingredients e.g.
lchthamol, Sulphur ,
Zinc Undecenoate
DISADVANTAGES: Limited uptake of water – 5.8%. Bases are thinned with liquid macrogol or
propylene glycol. If need to incorporate
more water add higher alcohols e.g. cetostearyl alcohol.
-
Can reduce antibacterial activity of some agents e.g.
Phenol, quartenary ammonium compounds, Penicillin
-
Not occlusive, therefore tend to dehydrate skin and
decrease Percutaneous absorption.
Arbitrary included are semisolid
preparations produced thrrough use of bentonite, colloidal magnesium silicate,
pectin, sodium Algnate, also carbopol.
Pectin: A WATER product, WATER soluble, absorb large
quantity of WATER, useful in treating bedsores + stubborn ulcers.
Glyceryl monostearate: - in cosmetic bases Additive which increase water retaining capacity). It
is Incompartible with Acidic substances
Cellulos ederivatives MeC, Na
CarbMeCellulose stabilizer
Bentonite – insoluble in water but
when mixed with 8 – 10 parts it gels (resemble petrolatum), BUT dries , and becomes unstable on standing. When 10%
glycerin is added it becomes Humectant
Celloidal aluminium magnesium
silicate is a thickener, stabilizer
Carbopol – Acid polymer, dispenses
readily in water and is a thickener.
PREPARATION OF OINTMENTS
Objective:
To dispense uniformly throughout the vehicle a finely
subdivided or dissolved drug substances – i.e no lumps, free from grittiness. Therefore
methods of preparation must satisfy these criteria.
Two General Methods:
(i)
Mechanical
incorporation:
(a)
Ointment slab (also Ointment parchment) - This method needs two spatulas – one with
broad long blade (to provide a large rubbing surface) and a small one to remove
accumulated material from the large one.
-
Mechanical action is employed– roll wrist in a figure
8.
-
One can warm base to facilitate (easier) the process
(care with emulsion bases – over heating causes water loss.
-
Use small amount of levigating agent to form a
concentrate then dilute geometrically with the remainder of the base
-
Water soluble drugs can be dissolved in a small amount
of water, then incorporated in equal amount of lanolin.
(b)
Mortar and
Pestle
Best when a liquid is to be
incorporated or too large a quantity is to be handled.
-
Can warm the mortar to make the process easier.
-
The rest is similar as above.
(ii)
Fusion:
Used when harder, wax-like substances
are to be incorporated with softer ones.
Use water-bath.
(a)
Older idea – progress from substances of highest melting
point to lowest adding one at a time.
(b)
Recent: Melt
altogether – use lowest temperature and not too long, shorter time.
- Melting
time is shortened by grating wax components.
- Remove
discolored layer from base (oxidized part).
- After melting, stir ingredients until
congealed. If lumpy, re-melt.
- Can remove sediments by decanting, or
use muslin or gauze in a warmed strainer.
- Solid
ingredient are added just near congealing pt.
- Avoid
vigorous shirring after ointment has started to thicken to avoid aeration
PRESERVATIVES:
To maintain potency and integrity of product, and to protect
the health and safety by the consume a preservative is used. USP suggests that products applied topically
should be free from P. aerugunosa, S.
aureus.
Parabens –
methylparabens, Propylparaben
-
can sensitize.
SAFETY TOXICITY
Safety: Condition
of being safe from causing injury.
Toxicity: (specific product) – adverse effect on a system caused by
such a product acting for a given period of time of a specific dose level.
. .
Ointment bases cause instant or allergic reactions. Tests should be done
(especially for irritancy levels) both in animal and in man.
PACKAGING AND LABELLING
Ointment jars, metal or plastic tubes are
used.
Ointment jars:
-
Straight sided screw cap jars on glass or plastic
-
Clear, amber, or opaque,
Or white opaque,
plastic (high density polyethylene)
Tops – metal or composition
plastic, inner liners (assure dust and air-tight closure), can be paper or
plastic laminates.
-
Jars are filled less than capacity to avoid or minimize contact between ointment
and cap or liner. For elegance use a
flexible spatula to depress the centre (conically).
Ointment tubes:
May be made of tin or aluminum or
plastic .
Advantage: Use
of fingers is minimized.
Disadvantage: Metal: Metal contact and ion-catalysed instability.
Plastic: May stain or discolor by immigration of
coloured material onto plastic side wall. This can be minimized by internal
coating (epoxy film).
LABELLING
Label should attach to itself (i.e completely, encircle the
tube) to avoid obliteration, difficulty in reading or loss of label.
On large scale – Expiry date, and code lot (batch number)
are stamped on as part of tube crimping procedure.
OPTHALMIC OINTMENTS
Ointments for application to the eyelids should be from specially
selected and finely powdered chemicals.
(Vehicle must be of finest quality) –
- White/yellow,
soft paraffin
-
Mineral oil often with lanolin
- Non-irritating,
permit diffusions, retain
- are applied outside and edges of eyelids, conjunctiva, and
iris.
- Should not contain
particulate mater, .therefore reduce
amount of foreign particular matter contaminants
. .
Tests to be done
50 particles for 10 tubes, 1 particle
for
Should be sterile (harmful microorganism loss of sugar) i.e. use sterilized
ingredients under rigidly aseptic condition and must melt sterility test.
-
Containers must be sealed and temperature (to assess
sterility) at time of first.
-
Leakage test – no significant leakage in of 10 tubes
maintained at 60º for 8 hours.
Preparation.:
Petrolatum
vehicles and Medicaments are sterilized in heat in Hot air of 150ºC for 2 hours.
Utensils for compounding are
sterilized by autoclaving or wash slab with detergent, Empty tubes may be sterilized by storing them for 24 hours in
1:1000 solution of Benzalkonium chloride in 70% isopropyl alcohol and then to remove
alcohol by evaporation or just 70%
ethanol for 24 hours.
Packing: Use sterile disposable syringe (without
a needle) to transfer semi-fluid ointments to ointment tube or sterile aluminum
foil or powder paper. The procedure is carried out in laminar – flow hood to
minimize contamination.